Inovio Pharmaceuticals, Inc. INO
1.69 USD +0.06 (+3.68%)
Regular-session close
1.68 -0.01 -0.56%
After hours · Nov 18, 4:59 PM ET
1.56 Day range 1.71
0.56 52-week range 2.72
- YTD
- -2.87%
- 1 year
- -10.58%
News
benzinga.com INOVIO Submits Conditional Marketing Authorization Application To EMA For VOCERYQ In Adults with Recurrent Respiratory Papillomatosis VOCERYQ™, the first FDA-approved plasmid DNA-based immunotherapy, received FDA accelerated approval on October 30, 2026Recurrent Respiratory Papillomatosis (RRP) is a rare, debilitating HPV-related…
prnewswire.com INOVIO Submits Conditional Marketing Authorization Application to European Medicines Agency for VOCERYQ™ in Adults with Recurrent Respiratory Papillomatosis VOCERYQ™, the first FDA-approved plasmid DNA-based immunotherapy, received FDA accelerated approval on October 30, 2026 Recurrent Respiratory Papillomatosis (RRP) is a rare, debilitating HPV-related…benzinga.com HC Wainwright & Co. Reiterates Buy on Inovio Pharmaceuticals, Maintains $5 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Buy and maintains $5 price target.
benzinga.com Piper Sandler Reiterates Overweight on Inovio Pharmaceuticals, Lowers Price Target to $6 Piper Sandler analyst Edward Tenthoff reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and lowers the price target from $8 to $6.
prnewswire.com INOVIO to Participate in Upcoming Investor Conferences PLYMOUTH MEETING, Pa., Nov. 11, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from…benzinga.com Inovio Pharmaceuticals Q3 EPS $(0.50) Misses $(0.21) Estimate, Sales $298.901K Miss $3.631M Estimate Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.21) by 138.1 percent. This is a 42.53 percent increase over…
benzinga.com Jefferies Maintains Buy on Inovio Pharmaceuticals, Raises Price Target to $8 Jefferies analyst Roger Song maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Buy and raises the price target from $3 to $8.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 19.5% to $0.36 during Friday's pre-market session. The company's market cap stands at $27.1 million. Eton Pharmaceuticals (NASDAQ:ETON)…benzinga.com INOVIO Pharmaceuticals Commences Common Stock Offering; No Terms Disclosed INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers TransMedics Group (NASDAQ:TMDX) stock rose 17.6% to $81.16 during Thursday's after-market session. The company's market cap stands at $2.5 billion. The company's, Q3 earnings came out today.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 16.2% to $4.67 during Monday's after-market session. The market value of their outstanding shares is at $9.1 million. Cerus…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million. BeyondSpring (NASDAQ:BYSI) stock moved…
benzinga.com Crude Oil Tumbles 7%; ISM Manufacturing PMI Rises In October U.S. stocks climbed as manufacturing data beat estimates; consumer shares surged, oil fell 7%, and Inovio, Perion and Evgo rallied.
benzinga.com Inovio Stock Soars Following FDA Approval for Rare Respiratory Disease Immunotherapy Inovio stock surges after FDA accelerated approval of Voceryq, an immunotherapy reducing surgeries for adults with recurrent respiratory papillomatosis.
benzinga.com Dow Jumps Over 400 Points; Marriott Posts Upbeat Q3 Earnings U.S. stocks rose Monday, led by a 400-point Dow gain. Marriott beat estimates; Inovio surged 195%, while oil fell 6% and Karyopharm sank 79%.
benzinga.com Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Rise Ahead of Apple, Palantir Earnings; RYAAY, USLM, INO in Focus (UPDATED) U.S. stocks rose on Monday, as the Dow Jones, S&P 500, and Nasdaq 100 index futures advanced, following Friday's lower close.
benzinga.com This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday Analysts upgraded PMT, MHK, CRWD, INO and AON; targets rose for MHK, CRWD and INO, while PMT’s target fell.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) shares increased by 232.0% to $2.0 during Monday's pre-market session. The company's market cap stands at $62.2 million. AngioDynamics (NASDAQ:ANGO) shares…benzinga.com HC Wainwright & Co. Upgrades Inovio Pharmaceuticals to Buy, Announces $5 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Neutral to Buy and announces $5 price target.
benzinga.com Why Inovio Pharmaceuticals Shares Are Trading Higher By Over 230%; Here Are 20 Stocks Moving Premarket Inovio shares surged 230% premarket after FDA accelerated Voceryq approval; ClearOne and 22nd Century gained, while RedCloud fell 33.5%.
benzinga.com Apple, Marriott International and 3 Stocks to Watch Heading Into Monday Stocks in focus: Apple, Marriott and Estée Lauder report earnings; Inovio wins FDA approval, while U.S. Lime posts disappointing results.
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers Inovio Pharmaceuticals (NASDAQ:INO) stock moved upwards by 292.6% to $2.37 during Friday's after-market session. The market value of their outstanding shares is at $79.8 million. Capricor…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers XORTX Therapeutics (NASDAQ:XRTX) shares moved upwards by 19.3% to $1.14 during Tuesday's after-market session. The company's market cap stands at $1.8 million. Edesa Biotech (NASDAQ:EDSA)…
